Celebrating a Legacy of Low Protein Innovation: The Story of Stephen and Linda Fletcher

The Story of Stephen and Linda Fletcher

For more than 30 years, Stephen and Linda Fletcher have dedicated their lives to improving the quality of life for people living with PKU and other inherited metabolic disorders.

Since founding Firstplay Dietary Foods and establishing the Promin brand in 1993, their vision, determination, and compassion have helped shape the development of modern low protein nutrition. What began as a commitment to addressing the practical dietary challenges faced by individuals with PKU has evolved into a business recognised throughout the metabolic community for its innovation, quality, and patient-centred approach.

Through the Promin range, they have developed more than 70 low protein foods, including breads, pastas, flour mixes, convenience meals, snacks, and other specialist products designed to make dietary management easier and more enjoyable. However, the success of these products has never been measured solely by sales or product numbers. Instead, their greatest achievement lies in the meaningful difference they have made to the daily lives of individuals and families who rely on low protein foods every day.

The story of Stephen and Linda Fletcher is one of listening to patients, understanding real-world challenges, and finding practical solutions. From the outset, they recognised that living with PKU is about much more than simply following a medical diet. Food plays an essential role in family life, friendships, social occasions, education, and personal wellbeing. Their ambition was not only to provide nutritional options but also to help people participate more fully in the experiences many others take for granted.

Throughout the years, they have worked closely with metabolic dietitians, clinicians, specialist centres, patient organisations, and families across the UK and internationally. This collaborative approach has helped ensure that product development remains focused on genuine needs rather than assumptions. By engaging directly with those living with metabolic conditions, they have been able to create foods that offer greater convenience, improved taste, and a wider variety of choices.

Some of the company’s most significant milestones have come from identifying simple but important gaps in the market. One particularly memorable achievement was the development of Promin Fresh Bread. For many families, access to fresh low protein bread represented far more than a new product. It provided children with the opportunity to enjoy school lunches that looked similar to those of their classmates, helping them feel more included in everyday activities. Experiences such as these demonstrate how dietary innovation can have a meaningful impact on confidence, independence, and quality of life.

Over three decades, the world of metabolic healthcare has changed considerably. Advances in diagnosis, treatment, education, and dietary management have transformed outcomes for people living with inherited metabolic disorders. Throughout these changes, Stephen and Linda have remained committed to supporting patients through continual product improvement and a willingness to embrace new ideas. Their contribution to low protein innovation has helped expand expectations of what specialist foods can be, moving from basic dietary substitutes to products that deliver both functionality and enjoyment.

Their influence can also be seen in the trust they have built within the community. Many families have relied on Promin products for years, while others have introduced them to a new generation of children diagnosed with PKU. This continuity reflects the confidence that patients, caregivers, and healthcare professionals place in the company’s products and values.

At the heart of their success is a belief that individuals living with PKU deserve the same opportunities to enjoy food and social experiences as everyone else. Rather than accepting limitations, they have consistently sought ways to widen choice and improve accessibility. This mindset has positioned them among the most respected figures in specialist nutrition and has contributed significantly to the ongoing advancement of low protein dietary options.

Their dedication has been recognised by colleagues, healthcare professionals, and families throughout the metabolic community. Professor Anita MacDonald OBE described them as “visionaries who have never stopped innovating or caring”, a statement that captures both their professional achievements and their personal commitment to supporting those affected by inherited metabolic disorders.

As Firstplay Dietary Foods enters its fourth decade, the legacy created by Linda Fletcher and Stephen Fletcher continues to grow. New ideas, evolving patient needs, and continued advances in specialist nutrition provide opportunities for further development, yet the principles established in 1993 remain unchanged. A commitment to quality, innovation, and community continues to guide the business and its future direction.

Today, Stephen and Linda Fletcher are widely recognised for their longstanding contribution to low protein nutrition and their dedication to improving the lives of people living with PKU. Their journey demonstrates the power of innovation driven by compassion, showing how a deep understanding of patient needs can lead to lasting and meaningful change. Through decades of hard work, collaboration, and perseverance, they have helped transform the dietary landscape for thousands of families and created a legacy that will continue to benefit future generations.

Read the full feature in NSPKU News & Views, Issue 179 (Autumn 2025) to learn more about their remarkable journey, the growth of Promin, and the lasting impact they have had on the PKU and inherited metabolic disorders community.